Celgene vet Jackie Fouse grabs the reins of a Vivek Ramaswamy vant-up
Jackie Fouse has landed.
A little more than four months after Fouse said she was “retiring” as president of Celgene, she’s back running her own biotech as executive chairman of Dermavant, one of several new “vants” that Roivant chief Vivek Ramaswamy has kicked into play over the last three years.
Fouse wrapped up her final lap at Celgene a few days ago, ending a 3-month leg as a company adviser to see out her transition from the big biotech, which has perhaps the busiest dealmaking group in the industry. She moves from a top job at a bellwether company to a startup with a few advanced therapies in the clinic. And she tells me that the partnering work she did at Celgene will help her get started on her new job as executive chairman.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.